PharmiWeb.com - Global Pharma News & Resources
07-Jun-2022

SCRS Global Impact Partner Program Grows with Addition of Clinerion

BASEL, SWITZERLAND (PRWEB) JUNE 07, 2022

SCRS’ GIP Program provides a unique opportunity for sponsors, CROs and solution providers to engage and collaborate with SCRS and its site members. Becoming a GIP demonstrates Clinerion’s commitment to developing a deeper understanding of the needs of sites and contribute to the development of solutions in the clinical research marketplace.

Sean Soth, SCRS Senior Vice President of Strategy & Global Business Partnerships shared, “Intelligent patient data and analytics will be a pathway for site sustainability in the years ahead. Clinerion’s support of sites and their experience with patient search efficiency will provide unique insights for our audiences and industry. SCRS welcomes the Clinerion team’s ideas, dedication and insight to the Global Impact Partner program.”

“Clinerion is looking forward to a great collaboration with SCRS as a GIP member, based on our mutual principles of supporting clinical trial sites with access to trials, improving trial efficiency and sharing best practices,” said Luis Magalhaes, Clinerion’s Customer Solutions Director. “Clinerion’s worldwide network of hospitals can benefit greatly from SCRS’ expertise and we expect SCRS will benefit from Clinerion’s global reach as they expand beyond the USA. We have great expectations of our contacts with SCRS sites and the other GIP members.”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion's Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.
Clinerion website: http://www.clinerion.com
Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/PatientNetworkExplorerSolutions.html

For more information, please contact:
Le Vin Chin
Director, Head of Marketing & Communications
Clinerion Ltd
Elisabethenanlage 11, 4051 Basel, Switzerland
Tel.: +41 61 865 60 54
media@clinerion.com

About The Society for Clinical Research Sites

Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. SCRS is an influential voice for sites and an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise.
Our Voice. Our Community. Your Success.
Join the community.
SCRS website: http://www.MySCRS.org

For more information, please contact:
Marissa Hill
Communications Manager
Society for Clinical Research Sites
communications@myscrs.org

SCRS Global Impact Partner Program Grows with Addition of Clinerion

Editor Details

Related Links

Last Updated: 08-Jun-2022